Zenotech Laboratories Limited
ZENOTECH
Rank in Stocks
#25542
Zenotech Laboratories Ltd. is a pharmaceutical company specializing in the... Zenotech Laboratories Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of various medical products. Notably, its production activities include granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GMCSF). The company's range of injectable offerings is strategically targeted at niche therapeutic areas such as oncology (cancer treatment) and anesthesiology. Founded on June 15, 1989, Zenotech Laboratories Ltd. maintains its headquarters in Hyderabad, India.
Share Price
$0.41512745
Last synced: 2026-11-09
Market Cap
$25.34M
Change (1 day)
1.85%
Change (1 year)
-28.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Zenotech Laboratories Limited (ZENOTECH)
Category
Healthcare
Operating Margin for Zenotech Laboratories Limited (ZENOTECH)
Operating Margin as of November 2026 TTM: -10.41%
According to Zenotech Laboratories Limited's latest financial reports, its current operating margin (TTM) is -10.41%. At the end of 2025 the company had an operating margin of 8.76%.
Operating Margin history for Zenotech Laboratories Limited from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -10.41% | -218.84% |
| 2025 | 8.76% | -86.71% |
| 2024 | 65.93% | 163.72% |
| 2023 | 25.00% | -64.34% |
| 2022 | 70.11% | -531.45% |
| 2021 | -16.25% | -204.10% |
| 2020 | 15.61% | -126.78% |
| 2019 | -58.29% | -44.75% |
| 2018 | -105.51% | -83.31% |
| 2017 | -632.28% | 12.13% |
| 2016 | -563.87% | -3.30% |
| 2015 | -583.10% | -11.34% |
| 2014 | -657.71% | -14.75% |
| 2013 | -771.53% | 105.37% |
| 2012 | -375.67% | 87.53% |
| 2011 | -200.32% | 5.13% |
| 2010 | -190.54% | 2.34% |
| 2009 | -186.19% | 140.28% |
| 2008 | -77.49% | -526.94% |
| 2007 | 18.15% | -177.17% |
| 2006 | -23.52% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -105.99% |
US
|
|
| 31.60% | -103.04% |
SE
|
|
| 30.13% | -102.89% |
FR
|
|
| 29.76% | -102.86% |
HK
|
|
| 30.46% | -102.93% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Zenotech Laboratories Limited's operating margin
What is Zenotech Laboratories Limited's operating margin?
Zenotech Laboratories Limited's operating margin is -10.41%, as of Nov 2026.
What was Zenotech Laboratories Limited's operating margin in 2025?
In 2025, Zenotech Laboratories Limited's operating margin was 8.76%, compared with 65.93% in 2024.
How has Zenotech Laboratories Limited's operating margin changed since 2020?
From 2020 to 2025, Zenotech Laboratories Limited's operating margin was highest in 2022 (70.11%) and lowest in 2021 (-16.25%).
How does Zenotech Laboratories Limited's operating margin compare with similar companies?
Zenotech Laboratories Limited's operating margin (-10.41%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.